1/28
07:19 am
crdf
Cardiff Oncology (NASDAQ:CRDF) had its "buy" rating reaffirmed by analysts at HC Wainwright.
High
Report
Cardiff Oncology (NASDAQ:CRDF) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/28
02:26 am
crdf
Cardiff Oncology, Inc. (CRDF) Discusses Management Transition and Onvansertib Phase II Data Update in RAS-Mutated mCRC Transcript [Seeking Alpha]
High
Report
Cardiff Oncology, Inc. (CRDF) Discusses Management Transition and Onvansertib Phase II Data Update in RAS-Mutated mCRC Transcript [Seeking Alpha]
1/27
07:05 am
crdf
Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC
High
Report
Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC
1/27
07:00 am
crdf
Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development
High
Report
Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development
1/13
11:09 am
crdf
Cardiff Oncology: What Storms Can We Expect In 2026? The Case For Measured Enthusiasm [Seeking Alpha]
Low
Report
Cardiff Oncology: What Storms Can We Expect In 2026? The Case For Measured Enthusiasm [Seeking Alpha]
1/5
10:01 am
crdf
Cardiff Oncology (NASDAQ:CRDF) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $12.00 price target on the stock.
Medium
Report
Cardiff Oncology (NASDAQ:CRDF) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $12.00 price target on the stock.
12/22
01:41 pm
crdf
3 Penny Stocks With At Least $100M Market Cap [Yahoo! Finance]
Low
Report
3 Penny Stocks With At Least $100M Market Cap [Yahoo! Finance]
12/8
04:05 pm
crdf
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025
Low
Report
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025
12/8
07:00 am
crdf
Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference
High
Report
Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference
11/24
07:00 am
crdf
Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference